Compared with untreated patients, IV idursulfase was shown to improve height and weight but only in children older than 8 years, suggesting that a long-term evaluation period (treatment duration was not reported) is required to assess growth in patients with MPS II [46]. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.